Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Eris Lifesciences/Natco Pharma partner on semaglutide for India
Eris Lifesciences has announced a partnership with Natco Pharma for the commercialisation of semaglutide in India. Semaglutide, a GLP-1 receptor agonist, is the active ingredient in Novo Nordisk's weightloss and diabetes drug Wegovy/ Ozempic…
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Average Recommendation of 'Moderate Buy' from Analysts
Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) have earned a consensus recommendation of 'Moderate Buy' from the twelve research firms that are presently covering the firm, MarketBeat Ratings reports. One research…
Pharmalittle: We're reading about pharma lobbying, a disappointing Novo clinical trial, and much more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and the like has returned. Settling in may be a little more…
Insider Selling: BridgeBio Pharma (NASDAQ:BBIO) CEO Sells 28,053 Shares of Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CEO Neil Kumar sold 28,053 shares of the stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $71.39, for a total transaction of $2,002,703.67.
Vanguard Group Inc. Acquires 347,074 Shares of BridgeBio Pharma, Inc. $BBIO
Vanguard Group Inc. lifted its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 2.1% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 16,832,059 shares of the company's stock after purchasing…
Watch Trade Uncertainty Rattles Global Stock Markets | Open Interest 2/23/2026
Trade Uncertainty Rattles Global Stock Markets | Open Interest 2/23/2026 Get a jump start on the US trading day with Matt Miller and Dani Burger on 'Bloomberg Open Interest.' Trade uncertainty rattles markets again as President Trump moves forward…
India's drug regulator inspected 90% of cough syrup makers, found lapses, official says
India's drug regulator has inspected nearly 90% of the country's cough syrup makers and found compliance lapses, its chief said on Monday (January 23, 2026), amid heightened scrutiny after India-made syrups were linked to the deaths…
Futures Slide As Renewed Tariff Turmoil Shakes Global Markets
Stock futures slumped after Trump's weekend tariff tantrum added uncertainty to American trade policy and was another blow to bullish outlooks for 2026. The Supreme Court's tariff ruling means a big source of fiscal revenue from 2025 may have to be…
Artios Receives U.S. FDA Fast Track Designation for DNA Polymerase Theta (Polθ) Inhibitor ART6043 for Treatment of gBRCA-mutated HER2-Negative Breast Cancer
U.S. Fast Track designation of ART6043 underpinned by promising clinical data to date and high unmet need in gBRCA-mutated HER2-negative breast cancer Artios is launching a global randomized Phase 2 study to evaluate ART6043 in patients with…
Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is branded 'obsolete'
The owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials. Novo Nordisk's shares fell sharply on Monday after…
Axsome: Q4 Earnings Review: Solid Performance, But Pipeline May Be Overvalued (AXSM)
Axsome Therapeutics, Inc. delivered 66% full-year 2025 revenue growth to $638.5M, driven by Auvelity and Sunosi, but remains loss-making. Despite a robust pipeline and upcoming catalysts, I downgrade AXSM to Hold due to valuation risks and…
Kennedy doubles down on defense of Trump glyphosate order amid MAHA backlash
Health and Human Services Secretary Robert F. Kennedy Jr. is doubling down on his defense of President Trump's executive order boosting a controversial pesticide, which drew fury from members of the Make America Health Again (MAHA) movement. MAHA…
Croda International H2 Earnings Call Highlights
Croda International LON: CRDA reported 2025 results showing higher sales, improved profits, and early progress from its transformation program, while outlining a three-year financial framework aimed at lifting margins and cash generation by 2028.
Uri: Franz Weber Foundation feels 'vindicated' in marina project
The Federal Office for Spatial Development has clearly stated that the project with an artificial harbour would “seriously impair” the protected landscape on Lake Uri and is not eligible for approval, the press release stated. Around…
European Parliament pauses work ratifying EU-US tariff deal, amid fresh uncertainty
Work to remove long-standing tariffs on American industrial goods has been paused by the European Parliament, while Brussels waits to see exactly how US President Donald Trump's plans to rework his tariff agenda. The commitment to remove mostly…
Receive a Daily briefing on Pharma Industry News
Get Started